EUVIMEDEUVIMED entdecken
Crossref

TRPS1 function beyond breast: A retrospective immunohistochemical study on non‐breast cytology specimens

Amr Ali iD, Saroja Geetha, Dongling Wu, Karen Chau, Priyanka Karam, Seema Khutti iD, Silvat-Sheik Fayyaz, Kasturi Das iD, Cecilia Gimenez, Oana C Rosca

Diagnostic Cytopathology · 2024

DOI: 10.1002/dc.25359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2024. Verfasst von Amr Ali und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Immunohistochemistry, Repressor Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Trichorhinophalangeal syndrome type 1 (TRPS1) has emerged as a reliable immunohistochemistry (IHC) marker for identifying breast origin in metastatic carcinomas. This study investigates the utility of TRPS1 IHC in non‐breast cytology specimens. Materials and Methods A retrospective search of our pathology database for the year 2021 identified fluids (pleural and peritoneal) and liver, lung and bone fine needle aspirations (FNAs) with surgical follow‐up confirming non‐breast metastatic carcinomas. Cell blocks from cases with sufficient neoplastic cells underwent immunostaining using a rabbit polyclonal antibody against human TRPS1. Cases lacking tumor on deeper levels after the original work‐up were excluded from the study. Two pathologists independently interpreted the TRPS1 staining.

Results

Of 136 cases assessed, 31 (22.79%) exhibited positive TRPS1 staining, while 105 (77.21%) were nonreactive. Positivity rates were observed in tumors of Mullerian cell origin, gastrointestinal tract (GIT), and lung origin at 28.85%, 25%, and 21.57%, respectively. Of the tumors of Mullerian cell origin 10 (66.67%) were serous carcinomas, 4 (26.67%) were endometrioid carcinomas, and one (6.67%) was a clear cell carcinoma. Lung tumors comprised seven (63.64%) squamous cell carcinomas and four (36.36%) adenocarcinomas, while the gastrointestinal tumors consisted of 14 (80%) adenocarcinomas and one (20%) squamous cell carcinoma.

Conclusions

Although recognized as a sensitive marker for mammary carcinomas, TRPS1 immunostaining was also detected in Mullerian, lung, and GIT carcinomas. This highlights the significance of being cautious when depending solely on TRPS1 immunostaining to distinguish metastatic breast tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorImmunohistochemistryRepressor ProteinsFemaleHumansMaleBiopsy, Fine-NeedleBreast NeoplasmsDNA-Binding ProteinsRetrospective StudiesTranscription Factors

Stichwörter der Autor:innen

TRPS1breastcytologynon‐breast

Substanzen

Biomarkers, TumorDNA-Binding ProteinsRepressor ProteinsTranscription FactorsTRPS1 protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

ORCID-Profile: Amr Ali, Seema Khutti, Kasturi Das

Zitieren

APA

Ali, A., Geetha, S., Wu, D., Chau, K., Karam, P., Khutti, S., Fayyaz, S. S., Das, K., Gimenez, C., & Rosca, O. C. (2024). TRPS1 function beyond breast: A retrospective immunohistochemical study on non‐breast cytology specimens. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25359

Vancouver

Ali A, Geetha S, Wu D, Chau K, Karam P, Khutti S, et al. TRPS1 function beyond breast: A retrospective immunohistochemical study on non‐breast cytology specimens. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25359

BibTeX
@article{Ali2024,
  author = {Ali, Amr and Geetha, Saroja and Wu, Dongling and Chau, Karen and Karam, Priyanka and Khutti, Seema and Fayyaz, Silvat-Sheik and Das, Kasturi and Gimenez, Cecilia and Rosca, Oana C},
  title = {TRPS1 function beyond breast: A retrospective immunohistochemical study on non‐breast cytology specimens},
  journal = {Diagnostic Cytopathology},
  year = {2024},
  doi = {10.1002/dc.25359}
}
Kostenlos starten →